Noë AJ - Search Results

1

Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.

Noë AJ, Malapetsa A, Panasci LC. Noë AJ, et al. Mol Pharmacol. 1993 Jul;44(1):204-9. Mol Pharmacol. 1993. PMID: 8341272

2

Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts.

Malapetsa A, Bramson JL, Noë AJ, Panasci LC. Malapetsa A, et al. Among authors: noe aj. Cancer Chemother Pharmacol. 1992;31(2):146-50. doi: 10.1007/BF00685102. Cancer Chemother Pharmacol. 1992. PMID: 1280536

3

Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics.

Noë AJ, Malapetsa A, Panasci LC. Noë AJ, et al. Cancer Res. 1994 Mar 15;54(6):1491-6. Cancer Res. 1994. PMID: 8137253

4

Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase.

Malapetsa A, Noë AJ, Poirier GG, Desnoyers S, Berger NA, Panasci LC. Malapetsa A, et al. Among authors: noe aj. Mutat Res. 1996 Jan 2;362(1):41-50. doi: 10.1016/0921-8777(95)00030-5. Mutat Res. 1996. PMID: 8538647

5

SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): a novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake2 carrier, which mediates increased cytotoxicity.

Panasci LC, Marcantonio D, Noë AJ. Panasci LC, et al. Among authors: noe aj. Cancer Chemother Pharmacol. 1996;37(6):505-8. doi: 10.1007/s002800050421. Cancer Chemother Pharmacol. 1996. PMID: 8612302 No abstract available.

6

Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity.

Noë AJ, Marcantonio D, Barton J, Malapetsa A, Panasci LC. Noë AJ, et al. Biochem Pharmacol. 1996 Jun 28;51(12):1639-48. doi: 10.1016/0006-2952(96)00129-3. Biochem Pharmacol. 1996. PMID: 8687479

7

Poly(ADP-ribose) polymerase can bind melphalan damaged DNA.

Bramson J, Prévost J, Malapetsa A, Noë AJ, Poirier GG, DesNoyers S, Alaoui-Jamali M, Panasci L. Bramson J, et al. Among authors: noe aj. Cancer Res. 1993 Nov 15;53(22):5370-3. Cancer Res. 1993. PMID: 8221673

8

Alteration of the systemic antitumor activity of melphalan by sodium cyanate in MOPC-460D myeloma-bearing BALB/c mice.

Shenouda G, Hutchinson M, Noë A, Panasci L. Shenouda G, et al. J Surg Oncol. 1993 Feb;52(2):110-4. doi: 10.1002/jso.2930520211. J Surg Oncol. 1993. PMID: 8468973

9

Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.

Abu-Sanad A, Wang Y, Hasheminasab F, Panasci J, Noë A, Rosca L, Davidson D, Amrein L, Sharif-Askari B, Aloyz R, Panasci L. Abu-Sanad A, et al. Front Pharmacol. 2015 Jul 22;6:147. doi: 10.3389/fphar.2015.00147. eCollection 2015. Front Pharmacol. 2015. PMID: 26257651 Free PMC article.

10

Mitochondrial ROS and the Effectors of the Intrinsic Apoptotic Pathway in Aging Cells: The Discerning Killers!

Hekimi S, Wang Y, Noë A. Hekimi S, et al. Front Genet. 2016 Sep 14;7:161. doi: 10.3389/fgene.2016.00161. eCollection 2016. Front Genet. 2016. PMID: 27683586 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters